DexCom stock was on the rise Thursday after the maker of medical technology said it had received clearance from the U.S. Food and Drug Administration for a new glucose monitoring system.
On Tuesday, Baxter International Inc. BAX launched its next-generation patient monitoring device, the Welch Allyn Connex 360 Vital Signs Monitor. The Connex 360 monitor has received the FDA’s 510(k) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results